Febrile neutropenia is a serious medical emergency that occurs when patients undergoing cancer treatment develop a fever while having dangerously low levels of white blood cells, leaving them vulnerable to life-threatening infections that require immediate medical attention.

Understanding Febrile Neutropenia as a Medical Emergency

Febrile neutropenia represents one of the most dangerous complications that can occur during cancer treatment. This condition develops when a person’s body cannot produce enough neutrophils, which are specialized white blood cells responsible for fighting infections, and simultaneously develops a fever. The medical definition is specific: a single oral temperature measurement of 101°F (38.3°C) or higher, or a sustained temperature of 100.4°F (38°C) or more lasting at least one hour, combined with an absolute neutrophil count (ANC) of 500 cells per microliter or less, or an ANC of 1,000 cells per microliter that is expected to drop below 500 within the next 48 hours.^[1][2]

What makes this condition particularly alarming is that when neutrophil levels fall too low, even minor infections that a healthy person’s body would easily handle can rapidly become serious or life-threatening. The fever may be the only warning sign of an underlying infection, as patients with low neutrophil counts often cannot mount the typical inflammatory response that would normally cause redness, swelling, or warmth at an infection site. This means healthcare providers must act quickly based solely on the presence of fever, without waiting for other symptoms to appear.^[4]

How Common is Febrile Neutropenia?

Febrile neutropenia is far from rare among people receiving cancer treatment. Research shows that approximately 50% of patients undergoing chemotherapy will develop neutropenia at some point during their treatment course. Among those receiving chemotherapy, studies have found that roughly 1% develop febrile neutropenia, though this rate varies significantly depending on the type and intensity of cancer treatment being administered.^[3][7]

The condition represents the most common serious complication of cancer therapy and is considered an oncological emergency requiring urgent evaluation and treatment. Each year in the United States, approximately 60,000 people with cancer are hospitalized specifically due to neutropenia-related complications. When hospitalization occurs, the average length of stay is about 10 days, reflecting both the seriousness of the condition and the time needed for the body to recover sufficient neutrophil levels while fighting off potential infections.^[5][6]

Certain patients face higher risks than others. Those at particularly high risk include individuals with anticipated severe neutropenia lasting seven days or longer, patients undergoing allogeneic hematopoietic stem cell transplantation, and those with significant existing medical problems. The timing of neutropenia is also predictable in many cases: following chemotherapy, neutrophil counts typically drop to their lowest levels between 7 and 12 days after treatment, with counts beginning to recover approximately 3 to 4 weeks later.^[2][18]

What Causes Febrile Neutropenia?

The root cause of febrile neutropenia lies in damage to the bone marrow, the soft tissue inside bones where blood cells are produced. Cancer treatments, particularly chemotherapy and radiation therapy, work by targeting rapidly dividing cells. Unfortunately, these treatments cannot distinguish between cancer cells and healthy rapidly dividing cells, including those in the bone marrow that produce neutrophils. When bone marrow function is suppressed, the production of new neutrophils slows or stops, and existing neutrophils in the bloodstream are not replaced as they naturally die off.^[3][4]

Beyond the direct effect on neutrophil production, chemotherapy and radiation can also damage the protective barriers in the body, particularly the mucous membranes lining the gastrointestinal tract, mouth, and sinuses. These barriers normally act as the first line of defense against germs. When they are compromised, bacteria and other microorganisms can more easily invade the body. Additionally, central venous catheters, which are often used to deliver chemotherapy, can provide another pathway for germs to enter the bloodstream.^[4]

What makes diagnosing the specific infection challenging is that in most cases of febrile neutropenia—approximately 70%—doctors cannot identify the exact source or type of infection causing the fever. This is called a fever of unknown origin. When an infectious cause is documented, which happens in only about 30% of cases, it is most commonly bacterial in nature. The bacteria may be organisms that normally live harmlessly in or on the body but become dangerous when the immune system is weakened.^[1][6]

Types of Infections in Febrile Neutropenia

When infections can be identified in patients with febrile neutropenia, they fall into several categories. Bacterial infections are the most common and include both gram-positive bacteria such as Staphylococcus, Streptococcus, and Enterococcus species, and gram-negative bacteria. Particularly concerning are drug-resistant organisms that have become increasingly common, including Pseudomonas aeruginosa, Acinetobacter species, Stenotrophomonas maltophilia, Escherichia coli, and Klebsiella species. These organisms pose special treatment challenges because they may not respond to standard antibiotics.^[1][6]

While bacterial infections predominate, viral and fungal infections are also possible, especially in patients with prolonged or severe neutropenia. The release of inflammatory chemicals called cytokines by damaged epithelial cells can also cause fever during neutropenia, even without a clear infection present. This makes it difficult to determine whether fever indicates a true infection or is simply a result of tissue damage from cancer treatment.^[4]

Who is at Highest Risk?

Several factors significantly increase a person’s risk of developing febrile neutropenia during cancer treatment. Age plays a major role, with patients 65 years and older facing substantially higher risks. This increased vulnerability may relate to age-related changes in immune function, the presence of other chronic health conditions, and potentially reduced bone marrow reserve capacity compared to younger individuals.^[5]

Existing medical conditions compound the risk. People with chronic diseases such as diabetes, heart disease, lung disease, kidney disease, or liver disease have compromised overall health that makes them more susceptible to infections and less able to recover from them. Those who are underweight or have poor nutritional status lack the physical resources needed to support immune function and healing. Similarly, patients with difficulty performing basic physical activities may have reduced physiological reserves.^[5]

Treatment-related factors are equally important. Prior exposure to chemotherapy or radiation can have cumulative effects on bone marrow function. Patients with a history of persistently low white blood cell counts even before starting new treatment are at higher risk. Those with long-term weakened immune systems due to conditions like HIV, autoimmune diseases, or medications that suppress the immune system enter cancer treatment with already compromised defenses. Recent surgery, open wounds, or recent infections all indicate vulnerabilities that increase the likelihood of developing febrile neutropenia.^[5]

The specific type and intensity of cancer treatment also matters greatly. Certain chemotherapy regimens are known to cause more profound bone marrow suppression than others. Patients receiving particularly aggressive treatment protocols or combinations of multiple chemotherapy drugs face heightened risks. Those undergoing bone marrow or stem cell transplantation experience intentional and severe depletion of their immune systems as part of the treatment process, making febrile neutropenia an expected complication requiring careful monitoring and prevention strategies.^[2]

Recognizing the Symptoms

The hallmark symptom of febrile neutropenia is fever itself, which may be accompanied by chills or sweating. However, the presentation can be deceptively simple because many typical signs of infection are absent in neutropenic patients. Without sufficient neutrophils to mount an inflammatory response, patients may not develop the usual warmth, redness, or swelling at sites of infection. This means healthcare providers must maintain a high index of suspicion based on fever alone.^[7][16]

Beyond fever, patients should watch for subtle signs that might indicate infection. Mouth sores can develop as chemotherapy damages the mucous membranes, and these can become infected. A new cough or difficulty breathing might signal a respiratory infection, which is particularly dangerous in neutropenic patients. Abdominal or rectal pain could indicate infection in the gastrointestinal tract. Any new pain, even if mild, deserves attention because it might be the only clue to an underlying infection that is not producing typical inflammatory signs.^[5]

Some symptoms that would normally seem minor require immediate medical attention in the context of neutropenia. A slight burning sensation during urination, mild sore throat, or small area of skin irritation could all represent the beginning of serious infections. Because infections can progress rapidly when the immune system is compromised, there is no room for a wait-and-see approach. Any concerning symptom occurring alongside fever or even without fever but during a period of known neutropenia should prompt contact with the healthcare team.^[14]

Preventing Febrile Neutropenia and Infections

Prevention strategies begin before neutrophil counts drop and continue throughout the period of vulnerability. One of the most effective preventive measures is the use of medications called colony-stimulating factors or growth factors, such as filgrastim and pegfilgrastim. These medications stimulate the bone marrow to produce more neutrophils, potentially shortening the duration of neutropenia and reducing the severity of the drop in neutrophil counts. They are typically given as injections and may be started the day after chemotherapy. The decision to use these preventive medications depends on individual risk assessment and the specific chemotherapy regimen being used.^[5]

In specific high-risk situations, doctors may recommend prophylactic antibiotics or antifungal medications. For example, patients undergoing certain types of intensive chemotherapy or stem cell transplantation might receive medications like ciprofloxacin or levofloxacin to prevent bacterial infections, or fluconazole, posaconazole, or voriconazole to prevent fungal infections. However, the use of prophylactic antimicrobials requires careful consideration because it can contribute to the development of drug-resistant organisms and must be balanced against individual patient risk factors.^[8]

Lifestyle and hygiene measures play a crucial role in infection prevention during periods of neutropenia. Meticulous hand washing is perhaps the single most important action patients and their caregivers can take. Hands should be washed thoroughly with soap and water before eating, after using the bathroom, and after any potential exposure to germs. Patients should avoid crowded places where they might encounter people with infections, including shopping malls, movie theaters, and public transportation, especially during peak times. They should stay away from anyone who is sick, even with seemingly minor illnesses like colds.^[14][15]

Personal care requires special attention. Patients should use soft toothbrushes to avoid injuring the gums, which could create an entry point for bacteria. Dental floss should be avoided during severe neutropenia for the same reason. Women should use sanitary pads rather than tampons and should avoid douching. Rectal thermometers and suppositories should not be used because they could cause small tears in delicate tissue. Even minor injuries like cuts, burns, or sunburns must be prevented through careful daily activities, as any break in the skin’s protective barrier poses infection risk.^[15]

Food safety takes on heightened importance. Patients with severe neutropenia may need to avoid fresh fruits and vegetables that cannot be thoroughly cooked, as these can harbor bacteria even after washing. Foods should be cooked thoroughly, with special attention to avoiding undercooked meat, eggs, or seafood. Some doctors recommend a specific “neutropenic diet” during periods of highest risk, though practices vary among institutions. Patients should avoid fresh flowers in their living spaces, as soil and water can contain mold and bacteria. Pets should be kept clean, and patients should avoid handling pet waste or changing litter boxes.^[11][15]

How the Body Changes During Neutropenia

To understand febrile neutropenia at a deeper level, it helps to know how the condition affects normal body function. Neutrophils are the most abundant type of white blood cell in the bloodstream, typically making up 50% to 70% of all white blood cells. They are produced continuously in the bone marrow and released into the blood, where they circulate throughout the body, ready to respond to any sign of infection. When bacteria or other harmful organisms invade the body, neutrophils are among the first responders, moving quickly to the site of infection where they engulf and destroy the invaders.^[3]

The bone marrow serves as a factory for blood cell production, working constantly to replace cells as they age and die. Under normal circumstances, this production keeps pace with the body’s needs. However, chemotherapy and radiation work by interfering with cell division, and the rapidly dividing cells in the bone marrow are particularly vulnerable to these treatments. When bone marrow function is suppressed, the production line slows or stops. Because neutrophils have a relatively short lifespan—only about 6 to 8 hours in the bloodstream—levels drop quickly when new cells are not being produced to replace them.^[3]

The severity of neutropenia is classified based on the absolute neutrophil count. Mild neutropenia involves counts between 1,000 and 1,500 cells per microliter. At this level, infection risk is elevated but not dramatically so. Moderate neutropenia, with counts between 500 and 1,000 cells per microliter, carries higher risk. Severe neutropenia occurs when counts fall below 500 cells per microliter, and this is when the danger of serious infection becomes substantial. A particularly critical threshold is profound neutropenia, defined as counts below 100 cells per microliter, at which point the risk of bacteremia—bacteria in the bloodstream—increases significantly.^[1][3]

The physical barriers that normally protect the body also become compromised during cancer treatment. The lining of the mouth, throat, stomach, and intestines consists of rapidly dividing cells that are damaged by chemotherapy just as cancer cells are. As these protective linings break down, bacteria that normally live harmlessly in these areas can cross into the bloodstream. The skin, too, may become more fragile and prone to small breaks that serve as entry points for infection. When these barrier breakdowns occur in combination with low neutrophil counts, the body loses both its physical defenses and its cellular immune response, creating a perfect storm for serious infection.^[4]

The inflammatory response that normally signals infection also depends heavily on neutrophils. When an infection begins, these cells rush to the affected area and release chemicals that trigger inflammation—the characteristic warmth, redness, swelling, and pain that indicate the body is fighting an invader. Without adequate neutrophils, this inflammatory response cannot occur normally. This is why patients with severe neutropenia may have serious infections without the typical warning signs. A pneumonia patient might have a clear chest X-ray initially because there are not enough white blood cells to create the inflammatory changes that would show up on imaging. An infected wound might not become red or swollen. This absence of typical signs makes early detection dependent on vigilance for fever and any subtle changes in how a patient feels.^[7]

The fever itself in neutropenic patients may arise from different sources than in people with normal immune function. Besides indicating infection, fever can result directly from the cancer or from tissue damage caused by chemotherapy. The damaged cells release substances called cytokines that affect the body’s temperature regulation center in the brain. This means that not every fever in a neutropenic patient is caused by infection, though healthcare providers must assume infection is present until proven otherwise and treat accordingly. The challenge lies in distinguishing between these causes, which is often impossible based on symptoms alone, making empiric treatment—treatment started before the specific cause is known—the standard approach.^[4]